Skip to content Skip to footer

Flora growth appoints industry authority tim leslie as chairman of its newly formed advisory board

MIAMI, FLORIDA AND TORONTO, ONTARIO – January 6, 2022 — Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the Chairman of its newly formed Advisory Board.

The establishment of the Advisory Board comes as Flora continues to develop its corporate structure to include a robust roster of human capital. The appointment of Leslie aligns with Flora’s goal of working with the best leaders in the industry who will provide strategic counsel to the Company on matters that will fuel its growth. A Yale law graduate, Leslie has a strong pedigree of success, working with scaling companies including his two decades at Amazon, where he served as Vice President and Associate General Counsel responsible for building and managing Amazon’s international legal team before changing roles to oversee the international launch of Amazon Prime Video. Following his successful tenure at Amazon, Leslie made the leap to the burgeoning cannabis industry where he served as CEO of one of the world’s most authoritative digital cannabis data sources, Leafly. Since his time there, Leslie has served on the board of renowned cannabis companies before his appointment as Chairman of the Board of Advisors at Flora.

“The synergies could not be better aligned,” Leslie said. “I have watched how Flora, in a short time, has emerged as a leader in building a diversified global cannabis company, from its low-cost manufacturing to the clinical studies from its Flora Pharma division to its premium brand portfolio. I am excited by the prospect that Flora’s current clinical trials at the University of Manchester and in the US can lead to the development of new, safe, plant-based medications to treat universal health issues like fibromyalgia, brain health, and pain in an accelerated time frame. Navigating that type of international growth is difficult, and something I have deep experience with. I hope to leverage that knowledge to assist the Flora team in making sound strategic decisions that will fuel Flora’s growth on an international scale. I truly believe in the potential of the cannabis industry to improve the health, welfare and longevity of people around the globe. I feel that I have found the right fit in supporting this organization.”

Currently an Executive in Residence at Beloit College, Leslie also sits on the Board of Advisors of Endocanna Health, a start-up focused on leveraging DNA research to understand how cannabis interacts with the body and is a Member of the Board of New Frontier Data, the industry’s leading authority in statistical analysis of markets and behavior, as well as Vessel, Flora’s most recently acquired luxury cannabis consumer technology company.

“We are pleased and honored to have Tim join us as the first Chairman of our Advisory Board,” said Luis Merchan, President and CEO of Flora Growth. “Tim’s extensive resume of leading the growth of prominent companies and projects and his deep understanding of the cannabis industry make Tim the ideal candidate for this role. We will look to our newly established Advisory Board for counsel on how to amplify our growth opportunities both domestically and internationally. Tim will play a key role in advising on how best to navigate the regulatory framework of building a truly global company, something he specifically worked on in his time at Amazon. All in all, we could not have asked for a more qualified person to fill the role of Chairman and we truly thank Tim for his commitment to Flora and his belief in our mission and success.”

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit or follow @floragrowthcorp on social for more information.

Investor Relations Contact:

Evan Veryard

Public Relations Contact:

Cassandra Dowell

+1 (858) 264-6600

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing.  We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us.  Such forward-looking statements relate to future events or our future performance, including: the size of markets for cannabis and cannabis products; the collaboration with third parties; and our business prospects and opportunities.  You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms.  In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business.  These and other factors may cause our actual results to differ materially from any forward-looking statement.  Forward-looking statements are only predictions.  The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us.  We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.